On Tuesday, Century Therapeutics Inc (NASDAQ: IPSC) opened at On Tuesday, remained unchanged from the last session, before settling in for the closing price of $0.54. Price fluctuations for IPSC have ranged from $0.34 to $3.70 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 27.56%. Company’s average yearly earnings per share was noted 33.26% at the time writing. With a float of $38.84 million, this company’s outstanding shares have now reached $85.84 million.
Let’s determine the extent of company efficiency that accounts for 150 employees. In terms of profitability, gross margin is -51.52%, operating margin of -2108.03%, and the pretax margin is -1893.43%.
Century Therapeutics Inc (IPSC) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Century Therapeutics Inc is 54.86%, while institutional ownership is 34.95%. The most recent insider transaction that took place on Mar 10 ’25, was worth 1,375. In this transaction President and CEO of this company sold 2,235 shares at a rate of $0.61, taking the stock ownership to the 1,190,310 shares. Before that another transaction happened on Mar 10 ’25, when Company’s insider sold 2,360 for $0.61, making the entire transaction worth $1,451. This insider now owns 272,573 shares in total.
Century Therapeutics Inc (IPSC) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 33.26% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.06% during the next five years compared to 18.46% growth over the previous five years of trading.
Century Therapeutics Inc (NASDAQ: IPSC) Trading Performance Indicators
Check out the current performance indicators for Century Therapeutics Inc (IPSC). In the past quarter, the stock posted a quick ratio of 1.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.62, a number that is poised to hit -0.01 in the next quarter and is forecasted to reach -1.26 in one year’s time.
Technical Analysis of Century Therapeutics Inc (IPSC)
Looking closely at Century Therapeutics Inc (NASDAQ: IPSC), its last 5-days average volume was 0.76 million, which is a jump from its year-to-date volume of 0.52 million. As of the previous 9 days, the stock’s Stochastic %D was 92.12%. Additionally, its Average True Range was 0.05.
During the past 100 days, Century Therapeutics Inc’s (IPSC) raw stochastic average was set at 13.32%, which indicates a significant decrease from 90.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 94.74% in the past 14 days, which was higher than the 78.27% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5897, while its 200-day Moving Average is $1.2886. However, in the short run, Century Therapeutics Inc’s stock first resistance to watch stands at $0.5600. Second resistance stands at $0.5800. The third major resistance level sits at $0.6000. If the price goes on to break the first support level at $0.5200, it is likely to go to the next support level at $0.5000. Now, if the price goes above the second support level, the third support stands at $0.4800.
Century Therapeutics Inc (NASDAQ: IPSC) Key Stats
There are currently 86,045K shares outstanding in the company with a market cap of 46.46 million. Presently, the company’s annual sales total 6,590 K according to its annual income of -126,570 K. Last quarter, the company’s sales amounted to 4,170 K and its income totaled -36,070 K.
